Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis
- Study Title
- Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)
- Teva Identifier
- ALS-GA-201
- ClinicalTrials.gov Identifier
- NCT00326625
- Study Status
- Completed
- Trial Condition(s)
- Amyotrophic Lateral Sclerosis
- Interventions
- Drug: 40 mg glatiramer acetate | Drug: Placebo
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years to 70 Years
- Trial Duration
- July 31, 2006 - July 31, 2008
- Phase
- Phase 2
